Would it be easy for NVDA to announce the companies itβs not partnering with instead? It would also help to more easily bring shame to those companies
@KingachillesE One trial they donβt talk about is Main-Cav, Cabo + avelumab in UC, trial is expected to complete in December, could add additional upside to Cabo revs if +